[1]
M. Witkowska, S. Witkowska, M. Klimczak, A. Frydecka, M. Witkowski, and P. Smolewski, “Quality of life patients treated with rituximab intravenous versus subcutaneous in B-cell lymphomas: results from outpatient Hematooncology Clinic in Lodz”, OncoReview, vol. 11, no. 2(42), pp. 33-39, Jul. 2021.